RxDoctor Payments Data

Antonio Luis, MD

Psychiatry · Milledgeville, GANPI 1093958050

Payments from drug & device makers

$469in general payments, 2019–2025

Across 26 payments — averaging $18.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$123
  • Axsome Therapeutics, Inc.$74
  • Takeda Pharmaceuticals U.S.A., Inc.$56
  • Otsuka America Pharmaceutical, Inc.$40
  • Johnson & Johnson$38
  • Merck$32
  • plus $105 from 5 others

What the payments were for

  • Food & beverage$469100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$469 in reported general payments places this provider in the 50th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Medicare billing

Part B allowed, 2024
$44,964
Medicare patients
66
Services billed
455

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide83$41,934
BelsomraSuvorexant35$18,582
Lurasidone Hcl53$11,657
QelbreeViloxazine Hcl21$7,718
Lisdexamfetamine Dimesylate30$6,186
Aripiprazole126$4,893
Oxcarbazepine125$3,403
Bupropion XlBupropion Hcl157$2,422
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine25$2,237
Trazodone Hcl200$2,151
Desvenlafaxine Succinate ErDesvenlafaxine Succinate62$1,908
Quetiapine Fumarate180$1,891
Buspirone Hcl142$1,554
Ziprasidone Hcl16$1,398
Clonazepam167$1,275

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$56$41,93483 claims
MerckBelsomra$32$18,58235 claims
Lilly USA, LLCOlanzapine$23$1,09336 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 900 psychiatry providers in Georgia.

Other psychiatry in Milledgeville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →